Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KC Futures DAO aims to launch Kansas City’s first blockchain-driven innovation magnet
As the US races to catch up to Europe, Asia and the developing world with regard to crypto, blockchain and Web3 tech, can the careful creation of talent-attracting digital hubs help close the distance? Today’s global economy — and its hyper-competitive talent market — rightly sees rapidly advancing technology as a relentless force, said Troy Carlson,…
New summer pitch competition builds on KCMO capital programs’ early success; applications open now
A new pitch competition is expected to give impactful small businesses and startups an opportunity to gain broader exposure and win cash prizes as the city’s KC BizCare Office expands capital programs supporting entrepreneurs in Kansas City, Missouri. In late July, five selected business leaders are set to pitch their ideas to about 50 judges,…
Vytelle’s next expansion: A third IVF lab in Australia as startup scales reproductive solutions for beef, dairy farmers
A Lenexa-based agtech company’s 21st lab space is planned for Melbourne, Australia, as the global leader in bovine in vitro fertilization works to revolutionize the industry and give farmers unparalleled access to hormone-free IVF. The state-of-the-art facility — set to open later this year — will be Vytelle’s third lab in Australia following the opening…
‘Well, S***’ sign-maker and ‘native Cole Camp girl’ revitalizes rural downtown’s small business scene
Editor’s note: The following story was produced through a paid partnership with MOSourceLink, which boasts a mission to help entrepreneurs and small businesses across the state of Missouri grow and succeed by providing free, easy access to the help they need — when they need it. COLE CAMP, Missouri — What started as a side…